Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Interim Management Statement

8 Aug 2014 07:00

RNS Number : 6195O
Quintain Estates & Development PLC
08 August 2014
 



8 August 2014

 

Quintain Estates & Development PLC

("Quintain" / "Company" / "Group")

 

Interim Management Statement

 

Quintain, the London property investment and development specialist, today issues its Interim Management Statement for the period from 1 April to 7 August 2014.

 

Maxwell James, Chief Executive of Quintain, said:

 

"We are delighted with the progress being made at Wembley Park, most particularly residential sales momentum ahead of the next launch in September. The prices achieved remain ahead of expectations, demonstrating both the strength of buyer demand at these price points and the growing appeal of Wembley Park. Alongside this, the refinancing of our bank facilities at extended maturities provides the appropriate financial platform for the execution of our strategy."

 

Wembley Park

At North West Village, off plan sales are progressing well. Construction of the 475 home Emerald Gardens is well underway, and sales have been agreed on 94 of the 110 homes released to date. Of these 87 have exchanged contracts and a further 7 have been reserved at an average price of £573 per square foot. This equates to an average selling price per home of £355,000. The first completions, including the 143 homes that will seed Quintain's new Private Rental Sector (PRS) business, will take place during the first half of 2016, with the balance delivered over the subsequent 12 months. 

This robust sales performance reflects continued strong demand from buyers at this price point, which remains the most under supplied segment of the London housing market.

The new leisure and retail quarter at Wembley Park, focused around the London Designer Outlet centre, continues to act as an important differentiator for residential purchasers. Recent openings at London Designer Outlet include Helly Hansen, The North Face, Without Prejudice and Kurt Geiger and Next will open a 7,800 sq ft store next month, anchoring the south east corner of the centre.

Finance

The Company has signed agreements for the refinancing of £260 million of corporate revolving credit facilities with its key relationship banks. The key terms are broadly in line with the existing facilities with headline margins of 190 basis points and expiry dates extended from March 2016 to the last quarter of 2018 and 2019.

 

Taken together with the £115 million bond issued in 2013, Quintain now has £375 million of debt facilities with the average maturity at five years, providing the Group with a strong and flexible financial platform, with significant headroom, from which to continue the execution of its strategy.

 

ENDS - -

 

Enquiries

 

Quintain

Maxwell James, Chief Executive

Richard Stearn, Finance Director

 

New Office Address:

43-45 Portman Square

London

W1H 6LY

 

Tel: +44 (0)20 3219 2200

comms@quintain.co.uk

RLM Finsbury

Jenny Davey

Charlotte Whitley

 

Tel: +44 (0)20 7251 3801

Quintain@rlmfinsbury.com

 

 

Forward looking statements

This announcement is for information purposes only and contains certain forward-looking statements which, by their nature, involve risk and uncertainty because they relate to or depend upon future events and circumstances.

There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements, including a number of factors outside Quintain's control. All forward-looking statements are based upon information known to Quintain on the date of this announcement and no representation or warranty is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Quintain gives no undertaking to update forward-looking statements whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company should not be relied upon as an indicator of future performance.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLIFSETEITIIS
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.